There has been almost no research that has examined the relationship between psychopathology and treatment response in women substance abusers (SAs). The antisocial personality disorder (APD) diagnosis in particular has received little attention in women SAs. The existing research suggests that these variables may have a differential impact on outcome for women and men SAs. The proposed research will explore the relationship of psychopathology in general, and antisociality in particular, to treatment outcome in cocaine dependent women. Additionally, the research will include identification of predictors of substance use outcomes as well as determining at what level of program implementation a program is most cost effective for women. One hundred and fifty women entering residential treatment for cocaine dependence will be evaluated at six month intervals for a period of two years. The baseline assessments will include urine toxicology, the Addiction Severity Index (ASI), structured interviews for DSM-III-R Axis I and II disorders, various measures of antisociality, and a Risk for Aids Behavior Questionnaire (RAB). Other measures of risk for substance use will include social support, coping behaviors, self-help beliefs and behaviors, and self-efficacy questionnaires. Reassessments will be performed at six month intervals to determine patient outcome and stability of a number of the measures (e.g. Axis II disorders, coping skills). The information that the study will yield regarding the predictors of treatment response and course of addiction in women cocaine addicts will provide data which may suggest more effective treatment interventions for women SAs. Additionally, the research will develop a method of identifying what point in treatment is most cost effective for women cocaine addicts.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Comprehensive Center (P60)
Project #
5P60DA005186-11
Application #
2665360
Study Section
Project Start
Project End
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Franklin, Teresa R; Jagannathan, Kanchana; Hager, Nathan et al. (2018) Brain substrates of early (4h) cigarette abstinence: Identification of treatment targets. Drug Alcohol Depend 182:78-85
Wetherill, Reagan R; Jagannathan, Kanchana; Hager, Nathan et al. (2016) Influence of menstrual cycle phase on resting-state functional connectivity in naturally cycling, cigarette-dependent women. Biol Sex Differ 7:24
Woody, George E; Krupitsky, Evgeny; Zvartau, Edwin (2016) Antagonist Models for Relapse Prevention and Reducing HIV Risk. J Neuroimmune Pharmacol 11:401-7
Van Horn, Deborah H A; Drapkin, Michelle; Lynch, Kevin G et al. (2015) Treatment choices and subsequent attendance by substance-dependent patients who disengage from intensive outpatient treatment. Addict Res Theory 23:391-403
Franklin, Teresa R; Jagannathan, Kanchana; Wetherill, Reagan R et al. (2015) Influence of menstrual cycle phase on neural and craving responses to appetitive smoking cues in naturally cycling females. Nicotine Tob Res 17:390-7
Kampman, Kyle M; Lynch, Kevin G; Pettinati, Helen M et al. (2015) A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug Alcohol Depend 155:105-10
Goldman, Marina; Ehrman, Ronald N; Suh, Jesse J et al. (2015) Brief report: ""spiders-No, puppies-Go"", introducing a novel Go NoGo task tested in inner city adolescents at risk for poor impulse control. J Adolesc 38:45-8
McKay, James R; Drapkin, Michelle L; Van Horn, Deborah H A et al. (2015) Effect of patient choice in an adaptive sequential randomization trial of treatment for alcohol and cocaine dependence. J Consult Clin Psychol 83:1021-32
Clarke, T-K; Crist, R C; Ang, A et al. (2014) Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. Pharmacogenomics J 14:303-8
Clarke, Toni-Kim; Weiss, Amy R D; Ferarro, Thomas N et al. (2014) The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann Hum Genet 78:33-9

Showing the most recent 10 out of 111 publications